Peg-ginase Injection - 5 Milliliter Single Vial Use Only | Enzyme Therapy For Acute Lymphocytic Leukaemia, Nutrient Deprivation Mechanism, 1-year Shelf Life

PEG-ginase injection is a treatment for acute lymphocytic leukaemia (ALL). It operates by depriving tumour cells of essential nutrients and so reducing tumour cell proliferation. A health care provider will inject this drug into a muscle, under the skin, or into a vein, usually in a hospital environment. The dosage is determined by your medical condition as well as your reaction to treatment. Pre-medication will be prescribed by your doctor to assist prevent allergic reactions. Drink plenty of fluids while taking this drug, unless your doctor tells you differently. Most people do not experience all of the mentioned negative effects. The onset and duration of side effects are frequently predictable. Side effects are virtually typically reversible and will disappear after treatment is finished.